Clinical Trials Browser

Phase 1/2 × N-Ac-CHAVC-NH2 × Clear all

NCT00265057 2010-12-28

Study of ADH-1 Given Intravenously to Patients With Solid Tumors

Phase 1/2 Completed

GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms

NCT00225550 2007-08-06

A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors

Phase 1/2 Terminated

Neoplasms